Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Summary of Significant Accounting Policies [Abstract] |
|
| Schedule of Property and Equipment Estimated Useful Lives |
The Company depreciates its property and equipment for financial reporting purposes using the straight-line method over the estimated useful lives of the assets. The estimated useful lives are as follows: | Building | | 40 years | | Building improvements | | 15 years | | Land improvements | | 15 years | | Machinery & equipment | | 5 years |
|
| Schedule of Property and Equipment |
Property and equipment consisted of the following as of June 30, 2026 and December 31, 2025: | | | June 30,
2026 | | | December 31,
2025 | | | Land improvements | | $ | 60,137 | | | $ | 60,137 | | | Buildings | | | 1,302,401 | | | | 1,302,401 | | | Building improvements | | | 2,275,583 | | | | 2,275,583 | | | Machinery and equipment | | | 2,204,815 | | | | 2,204,815 | | | Total property and equipment | | | 5,842,936 | | | | 5,842,936 | | | Less: accumulated depreciation | | | (3,916,045 | ) | | | (3,820,893 | ) | | Property and equipment, net | | $ | 1,926,891 | | | $ | 2,022,043 | |
|
| Schedule of Intangible Assets |
Intangible assets consisted of the following as of June 30, 2026 and December 31, 2025: | | | June 30,
2026 | | | December 31,
2025 | | | Issued patents | | | | | | | | Gross carrying amount | | $ | 1,625,156 | | | $ | 1,585,894 | | | Less: accumulated amortization | | | (789,115 | ) | | | (749,467 | ) | | Issued patents, net | | | 836,041 | | | | 836,427 | | | Patents pending (not amortized) | | | 1,161,366 | | | | 1,155,196 | | | Total intangible assets, net | | $ | 1,997,407 | | | $ | 1,991,623 | |
|
| Schedule of Potentially Dilutive Common Stock Equivalents |
The following table presents potentially dilutive common stock equivalents that have been excluded from the calculation of dilutive loss per share for the three and six months ended June 30, 2025 as their inclusion would be anti-dilutive: | | | June 30,
2026 | | | Holdback Shares | | | 4,000 | | | Warrants - Public | | | 123,500 | | | Warrants - Private | | | 108,100 | | | Warrants - Series A | | | 340,315 | | | Placement Agent Warrants | | | 116,650 | | | Stock-based compensation - equity awards | | | 6,000 | | | Stock-based compensation - warrants | | | 12,000 | | | Total common stock equivalents excluded from dilutive loss per share | | | 710,565 | |
The following table presents potentially dilutive common stock equivalents that have been excluded in the calculation of dilutive income per share for the three months ended June 30, 2025, as their inclusion would be anti-dilutive. | | | June 30,
2025 | | | Holdback Shares | | | 4,000 | | | Warrants - Public | | | 123,500 | | | Warrants - Private | | | 108,100 | | | Warrants - Series A | | | 810,389 | | | Warrants - Series C | | | 2,461,538 | | | Warrants - Series D | | | 244,349 | | | Stock-based compensation - equity awards | | | 38,000 | | | Stock-based compensation - warrants | | | 12,000 | | | Arbor Lake Strategic Cooperation Consulting Agreement | | | 40,000 | | | HBC Earnout Shares | | | 450,000 | | | Total common stock equivalents excluded from dilutive loss per share | | | 4,291,876 | | The following table presents potentially dilutive common stock equivalents that have been included in the calculation of dilutive income per share for the six months ended June 30, 2025, as their inclusion would be dilutive. | | | June 30,
2025 | | | Warrants - Series A | | | 576,540 | | | Warrants - Series C | | | 1,715,677 | | | Stock-based compensation - equity awards | | | 32,136 | | | Total common stock equivalents included in dilutive income per share | | | 2,324,353 | |
|